dicentra Joins the Nutritional Capital Network as Their Exclusive Clinical Research Partner

dicentra, a leading clinical research organization (CRO) and regulatory consulting firm, has joined the Nutrition Capital Network ("NCN") as their exclusive clinical research partner.

TORONTO (PRWEB) September 28, 2020

dicentra, a leading clinical research organization (CRO) and regulatory consulting firm that specializes in addressing all matters related to safety, quality, and compliance for all product categories in the life sciences and food industries, has joined the Nutrition Capital Network ("NCN") as their exclusive clinical research partner.

"We are very excited to join the Nutrition Capital Network as their exclusive Clinical Research Partner. Our goal is to help advance the science of tomorrow's new leaders in the health and wellness space," said Alicja Wojewnik, President & CEO of dicentra.

This partnership also includes dicentra sponsoring the NCN – NPC Investor Meeting (October 14-15), the NCN Ingredients Technology Investors Meeting (October 20-21), the NCN Fall Investor Meeting (November 18-19), and the NCN Europe Investor Meeting (December 8-9).

"We are excited to welcome dicentra to our NCN network so our clients, investors, and presenters can reap the rewards of improving their science-driven approach," Mike Dovbish, Executive Director NCN

dicentra's CRO is backed by an industry-leading team of medical and regulatory experts and over 18 years of experience in safety, quality, and compliance.

"We are very happy to be partnering with dicentra which is one of the leading CRO firms in Canada and North America. Right now, it is more important than ever to have the right kind of science for the right kind of products as our industry thrives during COVID-19 and more eyes are on us," Thomas Aarts, Principal and Co-founder NCN

Visit dicentra's virtual booth at the NCN – NPC Investor Meeting (October 14-15), the NCN Ingredients Technology Investors Meeting (October 20-21), the NCN Fall Investor Meeting (November 18-19), and the NCN Europe Investor Meeting (December 8-9).

About dicentra
dicentra is a contract research organization and professional consulting firm that specializes in addressing all matters related to safety, quality, and compliance for all product categories in the life sciences and food industries. We evaluate, implement, and provide all the necessary support for your products and operations, allowing you to gain market access while building confidence in your brand. We achieve this through our four business divisions: Life Sciences, Food Safety & Quality, Global Certifications, and Clinical Trials. Since our inception in 2002, we have completed over 18,000 projects and serviced over 1,200 companies internationally.

dicentra is headquartered in Toronto, Ontario and has an office in Guelph, Ontario. For more information, visit http://www.dicentra.com.

About Nutritional Capital
Nutrition Capital Network (NCN) is an organization that connects investors with high-potential growth companies in the nutrition and health & wellness Industry. Led by industry veterans and experienced investment professionals, NCN also provides cutting-edge, research-based industry knowledge and serves as a gateway to connections, insights and resources that support the growth of the nutrition and health & wellness industries. Since being founded in 2007, 545 companies have presented at 31 NCN investor meetings in the U.S. and Europe from a deal flow of more than 2,640 applicants.

For the original version on PRWeb visit: https://www.prweb.com/releases/dicentra_joins_the_nutritional_capital_network_as_their_exclusive_clinical_research_partner/prweb17425067.htm